Royalty Pharma plc logo

Royalty Pharma plc Investor Relations Material

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. The company's royalty acquisition segment engages in the acquisition of royalty streams from pharmaceutical companies. Its funding segment provides equity or loan financing to biotechnology companies developing innovative methods for the treatment of cancer, inflammatory disease, obesity, diabetes, and other metabolic disorders

Upcoming events for

Q3 20222022-11-10

Latest company events

Ticker symbol



United States of America

Dig deeper into the Royalty Pharma plc fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot